These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 28512184)

  • 1. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
    Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
    Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Blood Pressure Lowering Improves Left Ventricular Hypertrophy in Older Patients with Hypertension: The STEP Trial.
    Deng Y; Liu W; Yang X; Guo Z; Zhang J; Huang R; Yang X; Yu C; Yu J; Cai J;
    Hypertension; 2023 Sep; 80(9):1834-1842. PubMed ID: 37259845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
    Johnson K; Oparil S; Davis BR; Tereshchenko LG
    J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a meta-analysis of randomized trials.
    Hu J; Zhou Y
    Blood Press; 2023 Dec; 32(1):2242501. PubMed ID: 37652401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B;
    Ann Intern Med; 2007 Sep; 147(5):311-9. PubMed ID: 17785486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
    JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint Association of Albuminuria and Left Ventricular Hypertrophy With Incident Heart Failure in Adults at High Risk With Hypertension: A Systolic Blood Pressure Intervention Trial Substudy.
    Ahmad MI; Kazibwe R; Soliman MZ; Singh S; Chen LY; Soliman EZ
    Am J Cardiol; 2023 Dec; 208():75-82. PubMed ID: 37820550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Left Ventricular Hypertrophy a Valid Therapeutic Target?
    Brooks JE; Soliman EZ; Upadhya B
    Curr Hypertens Rep; 2019 May; 21(6):47. PubMed ID: 31111289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
    Ascher SB; de Lemos JA; Lee M; Wu E; Soliman EZ; Neeland IJ; Kitzman DW; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
    J Am Coll Cardiol; 2022 Oct; 80(16):1516-1525. PubMed ID: 36229087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
    Edison ES; Yano Y; Hoshide S; Kario K
    Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation.
    Soliman EZ; Rahman AF; Zhang ZM; Rodriguez CJ; Chang TI; Bates JT; Ghazi L; Blackshear JL; Chonchol M; Fine LJ; Ambrosius WT; Lewis CE
    Hypertension; 2020 Jun; 75(6):1491-1496. PubMed ID: 32362229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
    Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
    Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.